INTERNATIONAL CONSORTIUM INNOVATION & QUALITY PHARMACEUTICAL DEVELOPMENT 1500 K Street, NW, Suite 1100 Washington, DC 20005 Telephone Fax iqconsortium.org Mpiqconsortium.org 22 September 2023 Position Statement on the EU Restriction Proposal on PFAS from IQ Consortium General Position Statement This position statement was developed by the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ Consortium).

ELSEV ER Wear 266 (2009) 632-638 Contents lists available at ScienceDirect Wear journal homepage: www.elsevier.com/locate/wear A comparative investigation of the wear behavior of PTFE and PI under dry sliding and simulated sand-dust conditions Chunxia Li a' b' *, Fengyuan Yana a State Key Laboratory of Solid Lubrication, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China b Graduate School of Chinese Academy of Sciences, Beijing 100864, PR China ARTICLE INFO Article history: Received 31 August 2007 Received in revised form 23 June 2008 Accepted 6 August 2008 Available online 23 September 2008 Keywords: PTFE PI Simulated sand-dust Tribolayer ABSTRACT The wear behavior of polytetrafluoroethylene (PTFE) and polyimide (PI) has been comparatively evaluated under dry sliding and simulated sand-dust conditions.

Submission in support of time-unlimited derogation request for refrigerant R-474A for electric vehicles (2nd submission) Daikin Chemical Europe GmbH, Dsseldorf, Germany 22 September 2023 Contents 1.

5 September 2023 ToxProfiler Report Final version Toxys project code: Sponsor reference: Date: 23063 MA-RR-23-5046 2023 09 08 Toxys B.V.

Comment on Proposed Restriction of PFAS May 25, 2023 Japan Fluoropolymers Industry Association (JFIA) We, Japan Fluoropolymers Industry Association (JFIA), think that fluoropolymers should be distinguished from the proposed restriction of PFAS (Per- and polyfluoroalkyl substances), which collectively regulates more than 10,000 of organofluorine compounds (PFAS) on the grouping basis.

PFAS - geplante Beschrnkung Umfrage des AK Stoffpolitik/ Taskforce PFAS zur Betroffenheit der ZVEI-Mitgliedsunternehmen Juni 2021 bis August 2021 1.

<Document1 - Compatibility Mode.docx> 3

ANNEX XV RESTRICTION REPORT - PFAS IN FIREFIGHTING FOAMS ANNEX XV RESTRICTION REPORT PROPOSAL FOR A RESTRICTION (DRAFT) SUBSTANCE NAME(S): Polyfluoroalkyl and perfluoroalkyl substances (PFAS) in firefighting foams CONTACT DETAILS OF THE DOSSIER SUBMITTER: VERSION NUMBER: DATE: i ANNEX XV RESTRICTION REPORT - PFAS IN FIREFIGHTING FOAMS Question to the Commission: Are the proposed RMOs which will be assessed in more details clear and appropriate?

intended for the use of the individual to whom it is addressed.

Lead in shot consultation over, communication update of the proposal Tattoo inks campaign with a few Member States starting in November (link sent) Upcoming campaign on poisons centres and UFI DG ENV: new deputy ED for DG ENV, focuses on chemicals EP resolution on animal testing, Commission preparing a reply, goes to EP towards the end of October Round table stakeholder discussion on enforcement in preparation DG GROW: Tattoo conference mid-November by BfR, joins Resorcinol still pending, no conclusion on that yet, for December REACH committee Talk to you soon & Communications Unit European Chemicals Agency P.O.

Please find attached the slides presented and discussed today.

WP4 - Draft format structure report summary for 2nd "CfE" For all points: if info is mentioned...

Draft agenda for PFAS-RESTRICTION WEBEX Meeting between DE, DK, NL, NO, SE CA and ECHA 26 October 2020, 9:00 - 11:30 (CET) Login details: See below Point 1 - Opening and adoption of the agenda (9:00-9:10 am) Point 2 - Minutes and action points (9:10 - 9:20 am) 2020-10-20_PFAS RESTR-9 Minutes and APs_Draft of FINAL.docx 2020-10-20_Continued list of APs and their status.docx Point 3 - Status of COM/ECHA restriction on firefighting foams and relation with our work (9:20- 9:50 am) Maybe general discussion about the alignment with other PFAS restrictions Special attention to waste Point 4 - Status update WP1 (9:50 - 10:10 am) RMOA Discussion of draft RMOA template Discussion of possible restriction options (examples from previous restrictions) Call for evidence follow-up Information on Webinar 29 October Status on planning of stakeholder meetings and co-ordination Point 5 - Status update WP4 (10:10 - 10:30 am) All Member States to give an update on their/consultants work on the different subuses Outstanding issues Point 6 - Status update WP2 (10:30 - 10:40 am) Point 7 - Status update WP3 (10:40 - 10:50 am) Update from ECHA on status of sending output of HH hazard screening Point 8 - Status update WP7 (10:50 - 11:00 am) Point 9 -- Feedback from RiME+, 21/22 okt (11:00 -- 11:15 am) Informing group offeedback and discussions during RIME Point 10 --Action points, next steps & meetings (11:15-11:30 am) Requestfrom Chemicalwatchfor participation in webinar 3/12 Next WebEx meeting: November 23 WebEx Details ECHA Risk Management invites you to join this Webex meeting.

2nd Stakeholder Consultation on a Restriction for PFAS I.